Flannery K, Cavanaugh PF, Steele K. Reassessing (177)Lu-PSMA-617 Acquisition Costs: Implications for U.S. Radiopharmaceutical Therapy Cost-Effectiveness Analyses. J Nucl Med 2026 Sep 3:jnumed.126.272999. doi: 10.2967/jnumed.126.272999.
PMID: 42692829